Summary
Somatotroph adenomas often secrete prolactin (PRL) besides growth hormone (GH) and are sometimes immunostained for other anterior pituitary hormones or their subunits, such as thyroid-stimulating hormone (TSH) β-subunit and glycoprotein hormone α-subunit (αSU). However, Somatotroph adenomas showing hypersecretion of adrenocorticotropic hormone (ACTH) are extremely rare. There have been, to our knowledge, only five published reports on Somatotroph adenomas accompanied by excessive ACTH secretion. Here we report a case of intracavernously invading Somatotroph macro-adenoma with high serum GH, PRL, and ACTH levels. We examined the case using immunohistochemistry (IHC), in situ hybridization (ISH), and cell culture, and confirmed GH, PRL, and ACTH, as well as αSU, production, and the expression of Pit-1 protein by the adenoma, which is known as a transcriptional factor for GH, PRL, and TSH, not for ACTH. Therefore, the presence of unknown transcriptional factor other than Pit-1, common to GH, PRL, and ACTH, may be speculated to be expressed in this adenoma. In our previous study, we had found plurihormonal mRNA expression, especially for ACTH, the β-subunit of follicle-stimulating hormone and luteinizing hormone in some Somatotroph adenomas, using non-radio-isotopic ISH, and suggested that these adenomas might be derived from plurihormonal primordial stem cells. Our present case is significant from the viewpoint of histogenesis of pituitary adenomas, because it further supports the cell origin of Somatotroph adenomas from plurihormonal primordial stem cells, and moreover it suggests the presence of unknown transcriptional factor other than Pit-1, common to GH, PRL, and ACTH.
Similar content being viewed by others
References
Alexander JM, Biller BMK, Bikkal H, Zervas NT, Arnold A, Klibanski A (1990) Clinically nonfunctioning pituitary tumors are monoclonal in origin. J Clin Invest 86: 336–340
Arita K, Uozumi T, Kuwabara S, Mukada K, Kawamoto K, Takechi A, Onda J, Hara H, Egusa G (1991) A case of pituitary adenoma producing both growth hormone (GH) and adrenocorticotropic hormone (ACTH). Endocrinol Jpn 38: 271–278
Asa SL, Kovacs K, Horvath E, Singer W, Smyth HS (1992) Hormone secretion in vitro by plurihormonal pituitary adenomas of the acidophil cell line. J Clin Endocrinol Metab 75: 68–75
Biller BMK, Alexander JM, Zervas NT, Hedley-Whyte ET, Arnold A, Klibanski A (1992) Clonal origins of adrenocorticotropin-secreting pituitary tissue in Cushing's disease. J Clin Endocrinol Metab 75: 1303–1309
Bugalho MJGM, Nunes JFM, Sobrinho LG, Medina E, Campos JAM, da Silva CG, Clode AL (1993) Multihormonal response to CRH in a patient with Cushing's syndrome and a pituitary adenoma producing ACTH and GH. Acta Endocrinol 128: 289–292
Chatelain A, Dupouy JP, Dubois MP (1979) Ontogenesis of cells producing polypeptide hormones (ACTH, MSH, LPH, GH, prolactin) in the fetal hypophysis of the rat: influence of the hypothalamus. Cell Tissue Res 196: 409–427
Clore JN, Sharpe AR, Sahni KS, Kovacs K, Blackard WG (1988) Thyrotropin-induced hyperthyroidism: evidence for a common progenitor stem cell. Am J Med Sci 295: 3–5
Fukamachi Y, Yokoyama Y, Miyasato H, Matsusaki I, Kanzaki K, Tanaka H, Nawada S, Ibayashi H (1988) A case of Cushing's disease presenting with hypersecretion of GH and PRL five years after adrenalectomy. Clin Endocr (Tokyo) [Suppl 9] 35: 2123 (Jpn)
Gicquel C, Bouc YL, Luton JP, Girard F, Bertagna X (1992) Monoclonality of corticotroph macroadenomas in Cushing's disease. J Clin Endocrinol Metab 75: 472–475
Herman V, Fagin J, Gonsky R, Kovacs K, Melmed S (1990) Clonal origin of pituitary adenomas. J Clin Endocrinol Metab 71: 1427–1433
Jacoby LB, Hedley-Whyte ET, Pulaski K, Seizinger BR, Martuza RL (1990) Clonal origin of pituitary adenomas. J Neurosurg 73: 731–735
Kovacs K, Horvath E (1986) Tumors of the pituitary gland. In: Hartmann WH (eds) Atlas of tumor pathology. Second series, Fascicle 21. Armed Forces Institute of Pathology, Washington, pp 70–93
Kovacs K, Lloyd RV, Horvath E, Asa SL, Stefaneanu L, Killinger DW, Smyth HS (1989) Silent somatotroph adenomas of the human pituitary. Am J Pathol 134: 345–353
Karin M, Castrillo JL, Theill LE (1990) Growth hormone gene regulation: a paradigm for cell-type-specific gene activation. Trends Genet 6: 92–96
Li J, Stefaneanu L, Kovacs K, Horvath E, Smyth HS (1993) Growth hormone (GH) and prolactin (PRL) gene expression and immunoreactivity in GH- and PRL-producing human pituitary adenomas. Virchows Archiv A Pathol Anat 422: 193–201
Lloyd RV, Cano M, Chandler WF, Barkan AL, Horvath E, Kovacs K (1989) Human growth hormone and prolactin secreting pituitary adenomas analyzed by in situ hybridization. Am J Pathol 134: 605–613
Lloyd RV, Jin L, Fields K, Chandler WF, Horvath E, Stefaneanu L, Kovacs K (1991) Analysis of pituitary hormones and chromogranin A mRNAs in null cell adenomas, oncocytomas, and gonadotroph adenomas by in situ hybridization. Am J Pathol 139: 553–564
Matsuno A, Teramoto A, Takekoshi S, Sanno N, Osamura RY, Kirino T (1995) Expression of plurihormonal mRNAs in somatotroph adenomas detected using a non-isotopic in situ hybridization method: comparison with lactotroph adenomas. Hum Pathol 26: 272–279
Matsuno A, Teramoto A, Takekoshi S, Sanno N, Osamura RY, Kirino T (1995) HGH, PRL and ACTH gene expression in clinically non-functioning adenomas detected with non-isotopic in situ hybridization method. Endocr Pathol 6: 13–20
Matsuno A, Teramoto A, Takekoshi S, Utsunomiya H, Ohsugi Y, Kishikawa S, Osamura RY, Kirino T, Lloyd RV (1994) Application of biotinylated oligonucleotide probes to the detection of pituitary hormone mRNA using Northern blot analysis, in situ hybridization at light and electron microscopic levels. Histochem J 26: 771–777
Müller OA, Fink R, Werder KV, Scriba PC (1978) Hypersecretion of ACTH, growth hormone and prolactin in a patient with pituitary adenoma. Acta Endocrinol [Suppl 215] 87: 4–5
Sanno N, Inada K, Utsunomiya H, Umemura S, Itoh Y, Matsuno A, Teramoto A, Osamura RY (1994) Expression of Pit-1 product in human pituitaries: histochemical studies using an antibody against synthetic human Pit-1 protein. Med Sci Res 22: 685–687
Sanno N, Teramoto A, Matsuno A, Takekoshi S, Osamura RY (1996) Studies on GH and PRL gene expression by non-radioisotopic in situ hybridization in TSH-secreting adenomas. J Clin Endocrinol Metab 80: 2518–2522
Scanarini M, Mingrino S (1979) Pituitary adenomas secreting more than two hormones. Acta Neuropathol 48: 67–72
Schulte HM, Oldfield EH, Allolio B, Katz DA, Berkman RA, Ali IU (1991) Clonal composition of pituitary adenomas in patients with Cushing's disease: determination by X-chromosome inactivation analysis. J Clin Endocrinol Metab 73: 1302–1308
Simmoms DM, Voss JM, Ingraham HA, Holloway JM, Broide RS, Rosenfeld MG, Swanson LW (1990) Pituitary cell phenotypes involve cell-specific Pit-1 mRNA transformation and synergistic interactions with other classes of transcription factors. Genes Dev 4: 695–711
Song J, Jin L, Lloyd RV (1989) Effects of estradiol on prolactin and growth hormone messenger RNAs in cultured normal and neoplastic (MtT/W15 and GH3) rat pituitary cells. Cancer Res 49: 1247–1253
Thaper K, Stefaneanu L, Kovacs K, Horvath E, Asa SL (1993) Plurihormonal pituitary tumors: beyond the one cell-one hormone theory. Endocr Pathol 4: 1–3
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Matsuno, A., Sasaki, T., Mochizuki, T. et al. A Case of pituitary somatotroph adenoma with concomitant secretion of growth hormone, prolactin, and adrenocorticotropic hormone — an adenoma derived from primordial stem cell, studied by immunohistochemistry, in situ hybridization, and cell culture. Acta neurochir 138, 1002–1007 (1996). https://doi.org/10.1007/BF01411291
Issue Date:
DOI: https://doi.org/10.1007/BF01411291